Replies to post #197540 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I should clarify that I don't know the whole story, but that if what RK states is correct, then I'd feel I was mislead. The other way to look at it is NWBO had to keep extending the trial due to various circumstantial issues, like, perhaps, NICE requiring more proof of long term survivors in order to get a reasonable appraisal. If NWBO cynically started out with LPLV as their secret exclusive route to topline, then that's terrible (because of the incorrect timelines provided along the way), but if they were instead forced to extend the trial (wait on topline) to clear higher regulatory hurdles (which BTW Optune could not meet), then that's likely very different.